Treatment of 1st Line RCC selection of I-O and TKIs

Treatment of 1st Line RCC selection of I-O and TKIs
Don Photo

Don
3 years 89 Views
Category:
Description:
Michael B. Atkins MD at Georgetown Lombardi Comprehensive Cancer Center, Scholl Professor and Vice Chair Department of Oncology discusses how to select between different combinations of immuno-oncology and TKIs that are available and for the treatment of 1st line renal cell carcinoma (RCC).